BioAtla, Inc. (BCAB)
NASDAQ: BCAB · Real-Time Price · USD
0.2099
+0.0209 (11.06%)
At close: Feb 4, 2026, 4:00 PM EST
0.2058
-0.0041 (-1.95%)
After-hours: Feb 4, 2026, 7:53 PM EST

BioAtla Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
13341183917231,145
Market Cap Growth
-54.13%-70.91%-69.81%-45.97%-36.84%-
Enterprise Value
11-21-212174531,188
Last Close Price
0.210.592.468.2519.6334.01
PS Ratio
-3.12--2892.352668.76
PB Ratio
-2.401.672.173.435.45
P/TBV Ratio
-2.401.672.173.435.45
EV/Sales Ratio
----1812.652768.30
Debt / Equity Ratio
-0.200.060.040.020.030.00
Asset Turnover
-0.13--0.000.00
Quick Ratio
0.463.373.939.3212.377.40
Current Ratio
0.543.524.119.5312.487.46
Return on Equity (ROE)
--164.30%-98.37%-54.44%-45.34%-46.57%
Return on Assets (ROA)
-105.09%-53.71%-46.93%-28.15%-24.14%-14.80%
Return on Capital Employed (ROCE)
3164.50%-195.20%-142.00%-53.40%-41.10%-14.20%
Earnings Yield
-481.38%-203.40%-104.70%-27.26%-13.19%-3.13%
FCF Yield
-424.58%-209.70%-88.29%-23.21%-8.73%-3.23%
Buyback Yield / Dilution
-16.89%-1.67%-22.73%-12.63%-310.07%84.56%
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q